+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antiemetic Drugs Market - Global Forecast 2026-2032- Product Image
Antiemetic Drugs Market - Global Forecast 2026-2032- Product Image
New

Antiemetic Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924704
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antiemetic drugs market is undergoing significant evolution, shaped by clinical innovation and operational pressures across care settings. Senior decision-makers require granular insights to navigate this landscape, aligning therapeutic advancements and supply capabilities with shifting procurement and reimbursement demands.

Market Snapshot: Antiemetic Drugs Market Outlook

The Antiemetic Drugs Market expanded from USD 6.44 billion in 2025 to USD 7.01 billion in 2026 and is anticipated to achieve a CAGR of 9.00%, reaching USD 11.78 billion by 2032. Market growth is driven by demand spanning oncology, perioperative management, and radiotherapy support. Stakeholders experience rising expectations for innovative formulations, diverse delivery models, and supply assurance as healthcare trends move toward more integrated supportive care approaches.

Scope & Segmentation

  • Therapeutic Indications: Chemotherapy-induced, post-operative, and radiation-related nausea and vomiting management each require distinct strategic and clinical approaches.
  • Pharmacologic Classes: Includes corticosteroids, dopamine antagonists, neurokinin 1 receptor antagonists, and serotonin 5-HT3 receptor antagonists, which vary by efficacy and safety profiles across patient populations.
  • Administration Routes: Oral and intravenous delivery facilitate both inpatient and outpatient care strategies and influence packaging, adherence, and inventory needs.
  • End Users: Hospitals, clinics, and home care settings each have unique formulary, workflow, and patient support requirements shaping adoption.
  • Distribution Channels: Hospital pharmacy procurement, online pharmacies, and retail outlets affect accessibility, education, and adherence support for patients and institutions.
  • Regions: Americas, Europe Middle East & Africa, and Asia-Pacific are analyzed, reflecting variable infrastructure, regulatory policy, and procurement norms that alter market access and commercialization strategy.
  • Technology Drivers: Innovations include combination drug regimens, formulation refinements in key antagonists, digital remote monitoring, and emerging packaging solutions aimed at stability and patient adherence.

Key Takeaways: Strategic Insights for Antiemetic Drugs Market Stakeholders

  • Paradigm shifts move antiemetic management from basic symptom relief to a core component of patient adherence and treatment outcomes, increasing the importance of tolerability and clinical integration.
  • Evolving practice guidelines now favor multimodal prophylaxis and emphasize new neurokinin 1 and serotonin 5-HT3 receptor antagonist regimens, expanding options and complexity in treatment protocols.
  • Outpatient and home-based care trends are boosting demand for oral regimens and packaging innovations that support simplified dosing, stability, and monitoring, while pushing providers to reengineer delivery models.
  • Procurement and hospital formulary teams now weigh route-of-administration preferences, reimbursement strategy, and operational feasibility alongside clinical performance when selecting therapies for institutional adoption.
  • Manufacturers increasingly leverage partnerships, lifecycle management, and differentiation via patient support programs or digital therapeutics to improve competitive positioning as purchasing priorities shift.

Tariff Impact: Navigating 2025 US Policy Changes

Recent United States tariff realignments have introduced procurement complexity and new commercial risk factors into global antiemetic supply chains. Both API sourcing and finished product flows now demand supplier diversification, cost-to-serve scrutiny, and revised contract management. Hospital groups and integrated delivery networks recalibrate procurement frameworks to offset altered landed costs. Manufacturers are examining localized manufacturing and alternative formulations, while payers revisit preferred product lists and reimbursement paradigms in response to shifting cost pressures.

Methodology & Data Sources

This report employs a blended methodology incorporating clinician interviews, procurement leader feedback, regulatory analysis, and peer-reviewed evidence. In-depth qualitative inputs from oncology, anesthesia, and radiation therapy experts, combined with procurement professionals and supply chain managers, ensure findings reflect operational realities. Regulatory and literature reviews strengthen data accuracy and triangulation.

Why This Report Matters

  • Informs decision-makers on actionable alignment between clinical value, operational feasibility, and evolving commercial models for antiemetic therapeutics.
  • Enables manufacturers, payers, and providers to anticipate tariff effects, enhance procurement resilience, and adopt patient-centric delivery innovations.
  • Supports strategic planning for regional market entry, formulary negotiation, and partner development across global value chains.

Conclusion

The antiemetic drugs market stands at a pivotal convergence of clinical innovation, supply chain challenges, and evolving care delivery. Organizations that integrate clinical evidence with operational readiness will be well positioned to respond to dynamic market and procurement priorities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Antiemetic Drugs Market, by Indication
8.1. Chemotherapy-Induced Nausea And Vomiting
8.2. Post-Operative Nausea And Vomiting
8.3. Radiation-Induced Nausea And Vomiting
9. Antiemetic Drugs Market, by Drug Class
9.1. Corticosteroids
9.2. Dopamine Antagonists
9.3. Neurokinin 1 Receptor Antagonists
9.4. Serotonin 5-HT3 Receptor Antagonists
10. Antiemetic Drugs Market, by Route Of Administration
10.1. Intravenous
10.2. Oral
11. Antiemetic Drugs Market, by End User
11.1. Clinics
11.2. Home Care Settings
11.3. Hospitals
12. Antiemetic Drugs Market, by Distribution Channel
12.1. Hospital Pharmacy
12.2. Online Pharmacy
12.3. Retail Pharmacy
13. Antiemetic Drugs Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Antiemetic Drugs Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Antiemetic Drugs Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Antiemetic Drugs Market
17. China Antiemetic Drugs Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Acacia Pharma Limited
18.6. Akorn Operating Company LLC
18.7. Algen Healthcare Ltd.
18.8. Alkem Laboratories Ltd.
18.9. Cipla Limited
18.10. Dr. Reddy's Laboratories Limited
18.11. Fresenius Kabi Pte Ltd.
18.12. Glenmark Pharmaceuticals Limited
18.13. Global Calcium Private Limited
18.14. Helsinn Healthcare S.A.
18.15. Hikma Pharmaceuticals PLC
18.16. Lupin Limited
18.17. Merck KGaA
18.18. Novartis AG
18.19. Pax Healthcare
18.20. Pfizer Inc.
18.21. Sanofi S.A.
18.22. Saphnix Life Sciences
18.23. Scindia Pharma
18.24. Sun Pharmaceutical Industries Limited
18.25. Swastik Life Sciences
18.26. Teva Pharmaceuticals Industries Ltd.
18.27. Torrent Pharmaceuticals Ltd.
18.28. Viatris Inc.
18.29. Weefsel Pharma
List of Figures
FIGURE 1. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ANTIEMETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ANTIEMETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ANTIEMETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY POST-OPERATIVE NAUSEA AND VOMITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY POST-OPERATIVE NAUSEA AND VOMITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY POST-OPERATIVE NAUSEA AND VOMITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RADIATION-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RADIATION-INDUCED NAUSEA AND VOMITING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RADIATION-INDUCED NAUSEA AND VOMITING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY NEUROKININ 1 RECEPTOR ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY NEUROKININ 1 RECEPTOR ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY NEUROKININ 1 RECEPTOR ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 57. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 59. NORTH AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. NORTH AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 62. NORTH AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 63. NORTH AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. NORTH AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 65. LATIN AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. LATIN AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 67. LATIN AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 68. LATIN AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 69. LATIN AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 70. LATIN AMERICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 77. EUROPE ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. EUROPE ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 79. EUROPE ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 80. EUROPE ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 81. EUROPE ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. EUROPE ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. MIDDLE EAST ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. MIDDLE EAST ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 85. MIDDLE EAST ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 86. MIDDLE EAST ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 87. MIDDLE EAST ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 88. MIDDLE EAST ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 91. AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 92. AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 93. AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 94. AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 102. ASEAN ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 103. ASEAN ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 104. ASEAN ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 105. ASEAN ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. ASEAN ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. ASEAN ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 108. GCC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GCC ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 110. GCC ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 111. GCC ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 112. GCC ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. GCC ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 114. EUROPEAN UNION ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. EUROPEAN UNION ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 116. EUROPEAN UNION ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 117. EUROPEAN UNION ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 118. EUROPEAN UNION ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 119. EUROPEAN UNION ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 120. BRICS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. BRICS ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 122. BRICS ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 123. BRICS ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 124. BRICS ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. BRICS ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 126. G7 ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. G7 ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 128. G7 ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 129. G7 ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 130. G7 ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. G7 ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. NATO ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. NATO ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 134. NATO ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 135. NATO ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 136. NATO ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. NATO ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 140. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 141. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 142. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 143. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. CHINA ANTIEMETIC DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 146. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
TABLE 147. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 148. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 149. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Antiemetic Drugs market report include:
  • Acacia Pharma Limited
  • Akorn Operating Company LLC
  • Algen Healthcare Ltd.
  • Alkem Laboratories Ltd.
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Fresenius Kabi Pte Ltd.
  • Glenmark Pharmaceuticals Limited
  • Global Calcium Private Limited
  • Helsinn Healthcare S.A.
  • Hikma Pharmaceuticals PLC
  • Lupin Limited
  • Merck KGaA
  • Novartis AG
  • Pax Healthcare
  • Pfizer Inc.
  • Sanofi S.A.
  • Saphnix Life Sciences
  • Scindia Pharma
  • Sun Pharmaceutical Industries Limited
  • Swastik Life Sciences
  • Teva Pharmaceuticals Industries Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.
  • Weefsel Pharma

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.01 Billion
Forecasted Market Value ( USD ) by 2032 $ 11.78 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Antiemetics and Antinauseants Market Report 2025 - Product Image

Antiemetics and Antinauseants Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Antiemetics and Antinauseants Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Antiemetics and Antinauseants Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Antiemetic Drugs - Global Strategic Business Report - Product Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Electronic Antiemetic Device Market - Global Forecast 2025-2030 - Product Image

Electronic Antiemetic Device Market - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Low Frequency Pulse Antiemetic Device Market - Global Forecast 2025-2030 - Product Image

Low Frequency Pulse Antiemetic Device Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From

About the Antiemetic Market

The antiemetic market within the context of gastrointestinal drugs is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat nausea and vomiting. These drugs are used to treat a variety of conditions, including motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Antiemetics are also used to treat nausea and vomiting caused by certain medications, such as opioids. The antiemetic market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, Sanofi, and Takeda Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla, also offer antiemetic products. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.